NCT00403481

An Examination of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Patients With Type II Diabetes

A Prospective, Open Label, Single Arm Study to Evaluate the Safety and Efficacy of an Olmesartan Medoxomil Based Treatment Regimen in Type II Diabetic Patients With Hypertension

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 192 (actual)
• Sponsor: Daiichi Sankyo · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study will examine the ability of olmesartan medoxomil to lower the blood pressure of patients with Type II diabetes and high blood pressure. The medication being tested has been approved by the FDA for the treatment of high blood pressure.

Conditions

• Hypertension

Interventions

Type	Name	Description
DRUG	olmesartan medoxomil	Olmesartan medoxomil tablets, once daily
DRUG	Olmesartan medoxomil plus Hydrochlorothiazide	Olmesartan medoxomil and hydrochlorothiazide combination tablets, once daily, if necessary

Timeline

• Start date: 2006-11-01
• Primary completion: 2007-11-01
• Completion: 2007-12-01
• First posted: 2006-11-23
• Last updated: 2016-11-03
• Results posted: 2009-09-15

Locations

27 sites across 1 country: United States